Previous studies have shown that the urokinase plasminogen activator receptor (uPAR) is involved in the pathogenesis (both small airway fibrosis and emphysema) of COPD through complex molecular pathways and gene expression patterns [8–10]. This evidence concerns the gene PLAUR and chronic obstructive pulmonary disease.